Nanostructure drug platform
Various ocular diseases
Pre‑clinicalActive
Key Facts
About BioLight
Israel's sole publicly listed ophthalmology‑focused investment platform, BioLight builds a diversified portfolio of innovative eye‑care technologies.
View full company profile